PERSPECTA

News from every angle

← Back to headlines

Moderna Flu Shot Review Agreement Boosts Stock

Moderna's stock surged after the FDA reversed its stance and agreed to review the company's new flu shot.

18 Feb, 16:20 — 18 Feb, 16:20
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo6d ago

Moderna stock surges as FDA reverses course, agrees to review new flu shot

Read full article →

Related Stories

New 30% Income Tax for Banks Takes Effect in Poland

9m ago

Hedge Funds Actively Buying Specific Stock

26m ago

Top Dividend Stocks for Long-Term Investment

27m ago

Serbia's Average Net Salary Reaches 124,089 Dinars in December 2025

28m ago